B. Morgan

发表

Synthesis and structure of biomimetic porphyrins

D. Dolphin, B. Morgan, 1987 .

Enzyme reactions in apolar solvent. 6. The effect of double bond isomerism on the rate of PPL-catalyzed acylation of allylic alcohols

A. Oehlschlager, B. Morgan, 1993 .

Porcine pancreatic lipase mediated selective acylation of primary alcohols in organic solvents

A. Oehlschlager, B. Morgan, S. Ramaswamy, 1990 .

Effects of two types of dietary fibre on faecal steroid and lipid excretion.

D. Southgate, B. Drasar, M. J. Hill, 1975, British medical journal.

Highly stereoselective access to novel 2,2,4-substituted tetrahydrofurans by halocyclization: Practical chemoenzymatic synthesis of Sch 51048, a broad-spectrum orally active antifungal agent

W. Haiyan, V. Girijavallabhan, A. Ganguly, 1995 .

Enzymatic synthesis of enantio- and diastereomerically enriched syn-3-nitro-2-pentanol

D. Dodds, B. Morgan, Bhaskar R Sarikonda, 1999 .

A chemoenzymatic synthesis of both enantiomers of 2-phenyl-3-hydroxypropylcarbamate, a metabolite of felbamate

D. Dodds, B. Morgan, Greg Bydlinsky, 1995 .

The isolation of 2,3-oxidosqualene from the liver of rats treated with 1-dodecylimidazole, a novel hypocholesterolaemic agent.

B. Morgan, K. H. Baggaley, J. Green, 1972, The Biochemical journal.

Rapid identification of enantioselective ketone reductions using targeted microbial libraries

Brian Morgan, E. Previte, D. Dodds, 2004 .

A convenient synthesis of both enantiomers of seudenol and their conversion to 1-methyl-2-cyclohexen-1-Ol (MCOL)

B. Johnston, A. Oehlschlager, B. Morgan, 1991 .

Chemoenzymatic approaches to the dynamic kinetic asymmetric synthesis of aromatic amino acids

M. Burk, Jeffrey B. McQuaid, J. Chaplin, 2004 .

Biocatalysis in Pharmaceutical Process Development SCH56592, A Case Study

D. Dodds, B. Morgan, A. Zaks, 2001 .

Inhibitors of blood platelet aggregation. Effects of some 1,2-benzisothiazol-3-ones on platelet responsiveness to adenosine diphosphate and collagen.

B. Morgan, K. H. Baggaley, P. D. English, 1985, Journal of medicinal chemistry.

Synthesis of hydrocarbon-strapped porphyrins containing quinone and phenolic groups

D. Dolphin, B. Morgan, 1987 .

Enzymatic Desymmetrization of Prochiral 2-Substituted-1,3-propanediols: A Practical Chemoenzymatic Synthesis of a Key Precursor of SCH51048, a Broad-Spectrum Orally Active Antifungal Agent

D. Dodds, B. Morgan, A. Zaks, 1997 .

Chemoenzymatic approaches to SCH 56592, a new azole antifungal

B. Stockwell, D. Dodds, B. Morgan, 1997 .

Enzymatic Desymmetrization of Prochiral 2‐Substituted‐1,3‐propanediols: A Practical Chemoenzymatic Synthesis of a Key Precursor of SCH51048, a Broad‐Spectrum Orally Active Antifungal Agent.

D. Dodds, B. Morgan, A. Zaks, 1998 .

Inhibition of cholesterol biosynthesis by 1-alkylimidazoles.

R. M. Hindley, B. Morgan, K. H. Baggaley, 1975, Biochemical pharmacology.

Enzymatic kinetic resolution of piperidine atropisomers: synthesis of a key intermediate of the farnesyl protein transferase inhibitor, SCH66336.

R. Jain, D. Dodds, F. G. Njoroge, 2000, The Journal of organic chemistry.

Enzyme reactions in apolar solvent. 5. The effect of adjacent unsaturation on the porcine pancreatic lipase catalyzed kinetic resolution of secondary alcohols

T. M. Stokes, A. Oehlschlager, B. Morgan, 1992 .

Enzymatic Hydrolysis of a Prochiral 3‐Substituted Glutarate Ester, an Intermediate in the Synthesis of an NK1/NK2 Dual Antagonist

V. Sabesan, D. Dodds, B. Morgan, 2001 .

Pilot-Scale Lipase-Catalyzed Regioselective Acylation of Ribavirin in Anhydrous Media in the Synthesis of a Novel Prodrug Intermediate

G. Wong, B. Morgan, F. Bennett, 2003 .

The interactions between dietary saponin, cholesterol and related sterols in the chick.

B. Morgan, S. G. Brooks, J. Tee, 1972, Poultry science.

Dietary fibre and sterol metabolism in the rat

E. Chain, B. Morgan, J. Green, 1974, British Journal of Nutrition.

The role of cytochrome P-450 in cholesterol biogenesis and catabolism.

M. Cawthorne, B. Morgan, E. Palmer, 1972, Biochemical Journal.

Hypolipidemic analogues of ethyl 4-benzyloxybenzoate.

R. Fears, R. M. Hindley, B. Morgan, 1977, Journal of medicinal chemistry.

The participation of ethyl 4-benzyloxybenzoate (BRL 10894) and other aryl-substituted acids in glycerolipid metabolism.

R. Fears, R. M. Hindley, B. Morgan, 1978, Journal of lipid research.

Biologically active substances

Joseph. Green, B. Morgan, K. H. Baggaley, 1978 .

Tetronic 701-a novel hypocholesterolaemic agent.

R. Hindley, B. Morgan, J. Green, 1976, Atherosclerosis.